2018
DOI: 10.1111/tan.13281
|View full text |Cite
|
Sign up to set email alerts
|

The major histocompatibility complex homozygous inbred Babraham pig as a resource for veterinary and translational medicine

Abstract: The Babraham pig is a highly inbred breed first developed in the United Kingdom approximately 50 years ago. Previous reports indicate a very high degree of homozygosity across the genome, including the major histocompatibility complex (MHC) region, but confirmation of homozygosity at the specific MHC loci was lacking. Using both direct sequencing and PCR‐based sequence‐specific typing, we confirm that Babraham pigs are essentially homozygous at their MHC loci and formalise their MHC haplotype as Hp‐55.6. This … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
36
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 32 publications
(38 citation statements)
references
References 22 publications
2
36
0
Order By: Relevance
“…Differential protection induced by a live attenuated ASFV has been observed between NIH cc and dd minipigs that are inbred for different swine leukocyte antigen ( SLA ) class I and class II molecules [ 26 ]. In addition, the eight antigens were originally selected for their immunogenicity in the inbred Large White Babraham line of pigs which are homozygous at the SLA locus [ 29 , 46 ]. Low resolution genotyping of the twenty-four pigs immunized with Antigen Pools A, B and C identified ten SLA class I and eleven SLA class II haplotypes ( Table 3 ).…”
Section: Resultsmentioning
confidence: 99%
“…Differential protection induced by a live attenuated ASFV has been observed between NIH cc and dd minipigs that are inbred for different swine leukocyte antigen ( SLA ) class I and class II molecules [ 26 ]. In addition, the eight antigens were originally selected for their immunogenicity in the inbred Large White Babraham line of pigs which are homozygous at the SLA locus [ 29 , 46 ]. Low resolution genotyping of the twenty-four pigs immunized with Antigen Pools A, B and C identified ten SLA class I and eleven SLA class II haplotypes ( Table 3 ).…”
Section: Resultsmentioning
confidence: 99%
“…As previous work identified a D1-like Ig domain fragment encoded within the KIR2DL1 gene (Hammond et al 2009 ), we investigated KIR2DL1 mRNA splicing using PCR and cDNA from six animals leveraged from a recent MHC genotyping study (Schwartz et al 2018 ). Oligonucleotide primers were designed using Primer3 (Rozen and Skaletsky 2000 ) and supplied by Integrated DNA Technologies, BVBA (Leuven, Belgium).…”
Section: Methodsmentioning
confidence: 99%
“…Despite centuries of agricultural selective breeding, the pig has maintained a significant level of SLA genetic diversity, with 227 class I and 211 class II alleles identified for Sus scrofa in the Immuno‐Polymorphism Database (IPD) MHC database to date, making analysis of the fine specificity of immune responses extremely difficult (Maccari et al, 2017). The inbred Babraham line of pigs, on the other hand, is SLA homozygous for class I SLA‐ 1*14:02; SLA‐2*11:04 and SLA‐3*04:03 and class II DRB1-*05:01, DQA-*01:03 and DQB1-*08:01 (Schwartz et al, 2018). This homozygosity enabled the use of peptide-SLA tetramers to the dominant NP antigen to track the CD8 response in tissues in this study (Tungatt et al, 2018).…”
Section: Discussionmentioning
confidence: 99%
“…Several inbred miniature pig breeds have been developed, including NIH and Yucatan, with defined swine leukocyte antigens (SLA type, the swine major histocompatibility complex) (Sachs et al, 1976; Choi et al, 2016). However, the inbred Babraham is the only example of a full-size inbred strain of pig, closely related to commercial breeds, making them an appropriate model to study diseases important to commercial pig production (Signer et al, 1999; Schwartz et al, 2018). The sharing of IAV strains between pigs and humans makes it an obvious species in which to study immunity to influenza and to test vaccines or therapeutic strategies prior to human clinical trials.…”
Section: Introductionmentioning
confidence: 99%